Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 of  16 نتائج ل ""Local""

فلترة النتائج

Collection : Dial@Usl-B (Universite Saint-Louis, Bruxelles) Subject : antineoplastic combined chemotherapy protocols Subject : medicine.disease Subject : survival rate فلترة بواسطة : موضوع
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence.

Subjects: Humans; Squamous Cell Carcinoma of Head and Neck; Cetuximab

  • Source: Oral oncology, Vol. 147, no./, p. 106587 (2023)

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma.

Subjects: Adult; Aged; 80 and over

  • Source: European journal of cancer, Vol. 147, p. 1-12 (2021)

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.

Subjects: Adult; Antibodies; Monoclonal

  • Source: Lancet (London, England), Vol. 396, no.10265, p. 1817-1828 (2020)

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Lymphomas with kidney involvement: the French multicenter retrospective LyKID study.

Subjects: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms

  • Source: Leukemia & lymphoma, Vol. 61, no.4, p. 887-895 (2020)

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.

Subjects: Aged; Antibodies; Monoclonal

  • Source: Lancet, Vol. 393, no. 10167, p. 156-167 (2019)

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008.

Subjects: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols

  • Source: Journal of clinical oncology, Vol. 37, no.34, p. 3192-3202 (2019)

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008.

Subjects: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols

  • Source: Journal of clinical oncology, Vol. 37, no.34, p. 3192-3202 (2019)

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Review of the quality of total mesorectal excision does not improve the prediction of outcome.

Subjects: Aged; Digestive System Surgical Procedures; Disease-Free Survival

  • Source: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, Vol. 18, no. 9, p. 883-8 (2016)

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study.

Subjects: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols

  • Source: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 26, no.9, p. 1941-1947 (2015)

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study.

Subjects: Adult; Kaplan-Meier Estimate; Leukemia

  • Source: The Lancet Oncology, Vol. 16, no.9, p. 1025-1036 (2015)

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
  • 1-10 of  16 نتائج ل ""Local""